Open Access

Expression of periostin according to endometrial cancer grade

  • Authors:
    • Dilsad Herkiloglu
    • Sefik Gokce
    • Ecmel Isik Kaygusuz
    • Ozge Cevik
  • View Affiliations

  • Published online on: May 17, 2022     https://doi.org/10.3892/ol.2022.13335
  • Article Number: 213
  • Copyright: © Herkiloglu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

While various molecular profiling methods have been described for the early diagnosis and prognostic process of endometrial cancer, the most common gynaecological cancer, the data obtained remain insufficient. The present study aimed to investigate the protein and gene expression of periostin and its role as a new biomarker in the diagnosis, treatment and prognosis of endometrial cancer. A total of 15 patients diagnosed with endometrial cancer at the Department of Pathology, Zeynep Kamil Training and Research Hospital (Istanbul, Turkey) and 15 patients who were operated on for non‑tumour‑related reasons, between December 2019 and May 2020, were included in the study. The cases diagnosed with endometrial cancer were divided into three groups: International Federation of Gynaecology and Obstetrics grades I, II and III. Pathology tumour blocks were selected for enzyme‑linked immunosorbent assay and PCR studies in which periostin gene expression and protein levels were measured, respectively. A significant increase in periostin gene expression was observed in the endometrial cancer samples compared with that in the controls (3.40±0.66 vs. 2.23±0.47). The protein level of periostin in the tissues was found to be higher in the endometrial cancer samples than that in the control group (1.59±0.31 vs. 0.94±0.22). The levels of periostin protein and gene expression detected in the endometrial cancer samples increased as the grade increased. To the best of our knowledge, the current study is the first to determine the levels of periostin protein and gene expression in endometrial cancer. The results suggested that periostin may be used as a biomarker in the determination of higher histological grade in endometrial cancer.
View Figures
View References

Related Articles

Journal Cover

July-2022
Volume 24 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Herkiloglu D, Gokce S, Kaygusuz EI and Cevik O: Expression of periostin according to endometrial cancer grade. Oncol Lett 24: 213, 2022
APA
Herkiloglu, D., Gokce, S., Kaygusuz, E.I., & Cevik, O. (2022). Expression of periostin according to endometrial cancer grade. Oncology Letters, 24, 213. https://doi.org/10.3892/ol.2022.13335
MLA
Herkiloglu, D., Gokce, S., Kaygusuz, E. I., Cevik, O."Expression of periostin according to endometrial cancer grade". Oncology Letters 24.1 (2022): 213.
Chicago
Herkiloglu, D., Gokce, S., Kaygusuz, E. I., Cevik, O."Expression of periostin according to endometrial cancer grade". Oncology Letters 24, no. 1 (2022): 213. https://doi.org/10.3892/ol.2022.13335